Randomised, Placebo-Controlled, Double-Blind Trial to Assess Efficacy and Safety of ELOM-080 in Outpatients with COVID-19
- DOI
- 10.1007/s12325-024-03093-4
- Published
- 2025-01-15
- Container
- Advances in Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12325-024-03093-4,
title = {Randomised, Placebo-Controlled, Double-Blind Trial to Assess Efficacy and Safety of ELOM-080 in Outpatients with COVID-19},
author = {Michael Dreher and Hanna-Teresa Heier and Andrea Kienle-Gogolok and Kristina Röschmann-Doose and Jörg Simon and Ravi Singhal and Heidrun Täschner and Jörn Thomsen and Joachim Weimer and Thomas Wittig and Otto Wonhas and Manuela Thinesse-Mallwitz},
year = {2025},
journal = {Advances in Therapy},
doi = {10.1007/s12325-024-03093-4},
url = {https://doi.org/10.1007/s12325-024-03093-4}
}RIS
TY - JOUR TI - Randomised, Placebo-Controlled, Double-Blind Trial to Assess Efficacy and Safety of ELOM-080 in Outpatients with COVID-19 AU - Michael Dreher AU - Hanna-Teresa Heier AU - Andrea Kienle-Gogolok AU - Kristina Röschmann-Doose AU - Jörg Simon AU - Ravi Singhal AU - Heidrun Täschner AU - Jörn Thomsen AU - Joachim Weimer AU - Thomas Wittig AU - Otto Wonhas AU - Manuela Thinesse-Mallwitz PY - 2025 JO - Advances in Therapy DO - 10.1007/s12325-024-03093-4 UR - https://doi.org/10.1007/s12325-024-03093-4 ER -
APA
Dreher, M., Heier, H., Kienle-Gogolok, A., Röschmann-Doose, K., Simon, J., Singhal, R., Täschner, H., Thomsen, J., Weimer, J., Wittig, T., Wonhas, O., & Thinesse-Mallwitz, M. (2025). Randomised, Placebo-Controlled, Double-Blind Trial to Assess Efficacy and Safety of ELOM-080 in Outpatients with COVID-19. Advances in Therapy. https://doi.org/10.1007/s12325-024-03093-4
Source records
- crossref · retrieved 2026-09-26T05:39:21.550Z